White Paper

Retail and Mail-Order Prescriptions Snapshot

While overall in-network prescription costs are trending down, some areas, like migraine medications, are on the rise. Our latest analysis looks at what’s driving these shifts.
By:

White Paper Summary

Key insights reveal significant shifts in the workers’ comp and auto pharmaceutical landscape that impact claim costs and injured employee care. Our analysis of in-network retail and mail order prescription data shows encouraging trends, including decreased overall prescription costs despite rising prices in key therapeutic categories like migraine medications. This comprehensive review examines evolving medication utilization patterns, specialty drug impact, and the continued decline in opioid usage to help stakeholders make informed decisions within their pharmacy programs.

Register to download the full content

 

To learn more from Enlyte, please visit their website.

Enlyte is a P&C industry leader providing claims technology innovations and connectivity solutions, specialty networks, case management, pharmacy benefit and disability management services. Serving over 2,000 entities, including a majority of Fortune 500 employers, Enlyte leverages its portfolio of solutions to simplify processes and improve outcomes for auto, workers’ compensation and disability claims.

More from Risk & Insurance